SCHEMBL4920085

SCHEMBL4920085

O=C(Nc1cccc(C(F)(F)F)c1)Nc1ccc(-c2ccc(C(=O)[C@@H]3CC[C@H]3C(=O)O)s2)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 8/20 0.57
KDR P35968 7/20 0.48
BRAF P15056 2/20 0.48
ABL1 P00519 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
CSF1R P07333 1/20 0.47
LYN P07948 1/20 0.47
KIT P10721 1/20 0.47
SRC P12931 1/20 0.47
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
FLT3 P36888 1/20 0.47
BLK P51451 1/20 0.47
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
IDH2 P48735 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4920081 1.00 DGAT1 (0.57) DGAT1KDRBRAFABL1LCK
SCHEMBL4917526 0.91 KDR (0.48) DGAT1KDRBRAFABL1LCK
SCHEMBL4922037 0.88 KDR (0.47) DGAT1KDRBRAFABL1LCK
SCHEMBL4921383 0.86 DGAT1 (0.68) DGAT1KDRABL1LCKFYN
SCHEMBL4914177 0.85 DGAT1 (0.60) DGAT1KDRBRAFABL1LCK
SCHEMBL4914171 0.85 DGAT1 (0.60) DGAT1KDRBRAFABL1LCK
SCHEMBL4914181 0.85 DGAT1 (0.60) DGAT1KDRBRAFABL1LCK
SCHEMBL4917522 0.84 KDR (0.45) DGAT1KDRBRAFABL1LCK
SCHEMBL4916343 0.77 DGAT1 (0.78) DGAT1MEN1MAPTHTTRAB9A
SCHEMBL4923400 0.74 DGAT1 (0.66) DGAT1KDRABL1LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US claimed
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT DGAT1 1/4885KDR 4607/4885BRAF 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.